Moderna, Inc. (MRNA)
49.04
-0.99
(-1.98%)
USD |
NASDAQ |
May 15, 16:00
48.88
-0.16
(-0.33%)
After-Hours: 20:00
Moderna Research and Development Expense (Quarterly) : 590.00M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amgen, Inc. | 1.719B |
| Biogen, Inc. | 471.10M |
| Gilead Sciences, Inc. | 1.354B |
| Arbutus Biopharma Corp. | 4.12M |
| AbbVie, Inc. | 2.472B |